________ is an immunomodulating agent that is administered through slow IV infusion to treat renal cell cancer.
A. Intron A
B. Infergen
C. Avonex
D. Proleukin
Answer: D
You might also like to view...
The nurse is admitting a client to the hospital unit with a diagnosis of marasmus. This diagnosis is most likely secondary to what?
A) A chronic disease B) A recent trauma C) The influence of affluence D) The quality of the protein in the diet
Which information will the nurse include for a patient contemplating a cochlear implant?
a. Cochlear implants require training in order to receive the full benefit. b. Cochlear implants are not useful for patients with congenital deafness. c. Cochlear implants are most helpful as an early intervention for presbycusis. d. Cochlear implants improve hearing in patients with conductive hearing loss.
When reviewing the trends in communicable diseases for a county, the community health nurse notes that there was an increased incidence of Lyme's disease
The nurse develops a plan for prevention and control integrating the understanding that this disease is most likely transmitted by which mode? A) Vector B) Airborne C) Vehicle-borne D) Direct
The nurse is counseling women at a crisis shelter about risk factors for increased intimate partner violence. What event is most likely to trigger an increase in abusive behaviors?
a. Moving to a new community b. Starting a new job c. Becoming pregnant d. The death of a grandfather